BJP targets Rahul Gandhi over remarks on drugs

Image
Press Trust of India New Delhi
Last Updated : Oct 10 2014 | 8:15 PM IST
BJP today targeted Rahul Gandhi over his allegation that the Narendra Modi government allowed prices of cancer and other drugs to shoot up, saying he was indulging in "false propaganda" because of "certain defeat" of the Congress in the assembly elections.
The ruling party released a list of drugs with their old and current prices to buttress its claim that the prices remain unchanged. The list also carried the price which the media reported quoting the Congress leaders.
"The number of drugs whose prices are kept under control was 440 before BJP came to power and now their count is 489.
"The prices of 108 non-scheduled drugs meant for treatment of cancer, diabetes or cardiovascular diseases have come down by 30 percent providing relief of Rs 350 cr to consumers," BJP spokesperson Sudhanshu Trivedi told reporters.
The statement of Rahul Gandhi is "factually incorrect, insensitive and immature. We strongly condemn it and see it as a false propaganda during election emerging out of the frustration of their certain defeat," he said.
Taking a dig at Gandhi, he said they never expected "much maturity and wisdom" from him "but he should do a little more homework before making such accusations".
Trivedi said, "He (Rahul) has just failed miserably in Lok Sabha polls. He is somebody who is a prime ministerial candidate since birth but did not speak much for 10 years in Lok Sabha. Being a senior member of the country's oldest party, he should practice some caution."
Trivedi also criticised Gandhi for allegedly telling people in his election meeting in Mewat yesterday that their children will die of cancer due to Modi government's policies.
Accusing the Modi government of working for "big businessmen," Gandhi had alleged yesterday that it lifted control on drug prices at the behest of some US companies which has led to cancer medicines costing over Rs 1 lakh instead of Rs 8000 earlier.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 10 2014 | 8:15 PM IST

Next Story